Minimally invasive and catheter-based therapies are increasingly being used in patients with structural heart diseases (SHD). Echocardiography and Contrast-enhanced Computed Tomography Angiography (CE-CTA) are used in procedural planning for evaluating suitability of these interventions in SHD. However, some patients may not be able to undergo CE-CTA due to renal impairment or history of severe contrast reaction to iodinated contrast agents. Cardiac magnetic resonance (CMR) imaging can be used as an alternative noninvasive cross- sectional imaging modality in such patients. Measurements required for planning transcatheter SHD interventions such as annular and vessel size, as well as qualitative and quantitative functional information, such as flow across a valve or structural defect can be obtained with MRI. Phase contrast MRI can be used to quantify intracardiac shunts. In this article, we discuss the emerging indications of MRI in preoperative assessment for minimally invasive and transcatheter interventions in structural heart diseases.